Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feldman

Showing results (881-890 of 921) with videos related to

Pageof 93
Sort By:
Circulation|July 20, 2017
Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)Tom Adriaenssens, Michael Joner, Thea C Godschalk, et al.
Eclinicalmedicine|March 7, 2022
Traumatic brain injury in precariously housed persons: Incidence and risksTiffany A O'Connor, William J Panenka, Emily M Livingston, et al.
Blood|October 18, 2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemiaJudith E Karp, Tatiana I Vener, Mitch Raponi, et al.
Blood|September 24, 2024
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohortMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
JACC. Cardiovascular Interventions|December 23, 2017
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort RegistryThea C Godschalk, Robert A Byrne, Tom Adriaenssens, et al.
Journal of Neurosurgery. Pediatrics|October 17, 2025
Effect of endoscopic third ventriculostomy on subsequent shunt failure: a Hydrocephalus Clinical Research Network studyMichael J Feldman, Hailey Jensen, Anastasia Arynchyna-Smith, et al.
Blood|December 26, 2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposideJudith E Karp, Karen Flatten, Eric J Feldman, et al.
Haematologica|April 2, 2026
Treatment of <i>TP53</i>-mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclaxMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
European Heart Journal|January 14, 2016
Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortiumJulia Riegger, Robert A Byrne, Michael Joner, et al.
Pageof 93

Showing results (881-890 of 921) with videos related to

Sort By:
Pageof 93
Circulation|July 20, 2017
Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)Tom Adriaenssens, Michael Joner, Thea C Godschalk, et al.
Eclinicalmedicine|March 7, 2022
Traumatic brain injury in precariously housed persons: Incidence and risksTiffany A O'Connor, William J Panenka, Emily M Livingston, et al.
Blood|October 18, 2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemiaJudith E Karp, Tatiana I Vener, Mitch Raponi, et al.
Blood|September 24, 2024
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohortMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
JACC. Cardiovascular Interventions|December 23, 2017
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort RegistryThea C Godschalk, Robert A Byrne, Tom Adriaenssens, et al.
Journal of Neurosurgery. Pediatrics|October 17, 2025
Effect of endoscopic third ventriculostomy on subsequent shunt failure: a Hydrocephalus Clinical Research Network studyMichael J Feldman, Hailey Jensen, Anastasia Arynchyna-Smith, et al.
Blood|December 26, 2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposideJudith E Karp, Karen Flatten, Eric J Feldman, et al.
Haematologica|April 2, 2026
Treatment of <i>TP53</i>-mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclaxMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
European Heart Journal|January 14, 2016
Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortiumJulia Riegger, Robert A Byrne, Michael Joner, et al.
Pageof 93